Portfolio Holdings Detail for ISIN IE00B43HR379
Stock Name / Fund iShares S&P 500 Health Care Sector UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares V Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300QETNU1W5JY7Z94
ETF Ticker IHCU(GBX) LSE
ETF Ticker IUHC(USD) LSE
ETF Ticker QDVG(EUR) F
ETF Ticker IHCU.LS(GBX) CXE
ETF Ticker IUHC.LS(USD) CXE
ETF Ticker IUHCz(USD) CXE
ETF Ticker QDVG.DE(EUR) CXE
ETF Ticker IHCU.L(GBP) LSE
ETF Ticker IUHC.L(GBP) LSE

Holdings detail for DXCM

Stock Name	DexCom Inc
Ticker	DXCM(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US2521311074
LEI	549300YSK3QDSFR5EU59

Show aggregate DXCM holdings

News associated with DXCM

Implied QQEW Analyst Target Price: $156: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-22 07:55:44
Friday's ETF with Unusual Volume: QQH: The HCM Defender 100 Index ETF is seeing unusually high volume in afternoon trading Friday, with over 190,000 shares traded versus three month average volume of about 26,000. Shares of QQH were up about 0.6% on the day. Components of that ETF with the highest volume on Friday - 2025-09-19 13:23:32
Nasdaq 100 Movers: DXCM, FTNT: In early trading on Friday, shares of Fortinet topped the list of the day's best performing components of the Nasdaq 100 index, trading up 2.7%. Year to date, Fortinet has lost about 11.9% of its value. And the worst performing Nasdaq 100 component thus far on the day is DexCo - 2025-09-19 12:11:42
DexCom, Inc. (NASDAQ:DXCM) Receives $99.89 Consensus Price Target from Brokerages: Shares of DexCom, Inc. (NASDAQ:DXCM – Get Free Report) have been assigned an average rating of “Moderate Buy” from the twenty-two analysts that are presently covering the company, MarketBeat.com reports. Five equities research analysts have rated the stock with a hold recommendation, fourteen have given a buy recommendation and three have given a strong buy […] - 2025-09-18 03:01:05
Best Bang For Your Buck? 2 Bargain Stocks with 30%+ Upside: When it comes to identifying target stocks for investment, compelling prospects may include companies that are undervalued and, simultaneously, expected to appreciate in the future. Of course, timing an investment in one of these firms is notoriously difficult. It may help to lo - 2025-09-14 11:27:00
Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb: The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 13:38:14
Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb: The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 12:43:18
Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb: The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 12:13:06
Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb: The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 10:36:17
Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb: The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 08:39:38
Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb: The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 08:27:13
Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb: The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 06:09:22
DexCom (NASDAQ:DXCM) Downgraded by Oppenheimer to Market Perform: Oppenheimer cut shares of DexCom (NASDAQ:DXCM – Free Report) from an outperform rating to a market perform rating in a research report sent to investors on Monday, MarketBeat.com reports. Other research analysts have also recently issued research reports about the stock. Argus assumed coverage on shares of DexCom in a research report on Thursday, August […] - 2025-09-09 02:50:44
Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb: The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-08 22:27:11
DexCom, Inc. (NASDAQ:DXCM) Receives Consensus Recommendation of “Moderate Buy” from Analysts: DexCom, Inc. (NASDAQ:DXCM – Get Free Report) has been assigned an average rating of “Moderate Buy” from the twenty-two analysts that are presently covering the company, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold rating, fifteen have given a buy rating and three have issued a strong buy rating on […] - 2025-08-21 02:41:01
Leerink Partnrs Predicts DexCom’s Q3 Earnings (NASDAQ:DXCM): DexCom, Inc. (NASDAQ:DXCM – Free Report) – Investment analysts at Leerink Partnrs dropped their Q3 2025 earnings estimates for shares of DexCom in a report released on Wednesday, July 30th. Leerink Partnrs analyst M. Kratky now expects that the medical device company will post earnings of $0.57 per share for the quarter, down from their […] - 2025-08-04 02:46:55
DexCom (DXCM) Q2 Revenue Jumps 15%: Key PointsRevenue (GAAP) rose 15% year-over-year in Q2 2025, easily surpassing expectations and driven by strong U.S. and international growth. - 2025-08-01 01:53:01
Allianz Asset Management GmbH Decreases Stock Position in DexCom, Inc. (NASDAQ:DXCM): Allianz Asset Management GmbH lowered its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 22.9% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 73,079 shares of the medical device company’s stock after selling 21,698 shares during the period. Allianz Asset […] - 2025-07-29 04:42:53
DexCom (DXCM) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates: Besides Wall Street's top-and-bottom-line estimates for DexCom (DXCM), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025. - 2025-07-29 01:00:16
Private Advisor Group LLC Decreases Stock Position in DexCom, Inc. (NASDAQ:DXCM): Private Advisor Group LLC cut its holdings in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 11.1% during the 1st quarter, HoldingsChannel.com reports. The fund owned 13,461 shares of the medical device company’s stock after selling 1,688 shares during the period. Private Advisor Group LLC’s holdings in DexCom were worth $919,000 as of its most recent […] - 2025-07-28 05:22:58
HighPoint Advisor Group LLC Has $299,000 Holdings in DexCom, Inc. (NASDAQ:DXCM): HighPoint Advisor Group LLC cut its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 15.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,196 shares of the medical device company’s stock after selling 749 shares during the quarter. HighPoint Advisor Group LLC’s […] - 2025-07-24 05:51:13
AVLV's Underlying Holdings Imply 10% Gain Potential: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-07-21 10:15:07
DexCom (NASDAQ:DXCM) Upgraded at Wall Street Zen: Wall Street Zen upgraded shares of DexCom (NASDAQ:DXCM – Free Report) from a hold rating to a buy rating in a research report report published on Friday. A number of other equities research analysts have also commented on the company. Cfra Research upgraded DexCom to a “hold” rating in a research report on Friday, March […] - 2025-07-21 04:58:50
Morgan Stanley Forecasts Strong Price Appreciation for DexCom (NASDAQ:DXCM) Stock: DexCom (NASDAQ:DXCM – Get Free Report) had its target price increased by equities research analysts at Morgan Stanley from $82.00 to $89.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has an “equal weight” rating on the medical device company’s stock. Morgan Stanley’s price objective would indicate a potential upside […] - 2025-07-17 06:22:53
Cerity Partners LLC Grows Stock Holdings in DexCom, Inc. (NASDAQ:DXCM): Cerity Partners LLC grew its holdings in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 4.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 69,601 shares of the medical device company’s stock after acquiring an additional 2,711 shares during the period. Cerity Partners LLC’s […] - 2025-07-17 05:30:58
DexCom, Inc. (NASDAQ:DXCM) Shares Acquired by Stratos Wealth Partners LTD.: Stratos Wealth Partners LTD. increased its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 32.7% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 3,428 shares of the medical device company’s stock after buying an additional 845 shares during the quarter. Stratos […] - 2025-07-17 04:58:54
Allworth Financial LP Purchases 1,765 Shares of DexCom, Inc. (NASDAQ:DXCM): Allworth Financial LP lifted its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 163.3% during the 1st quarter, Holdings Channel reports. The firm owned 2,846 shares of the medical device company’s stock after acquiring an additional 1,765 shares during the period. Allworth Financial LP’s holdings in DexCom were worth $201,000 at the end of […] - 2025-07-16 05:18:51
Nisa Investment Advisors LLC Cuts Stake in DexCom, Inc. (NASDAQ:DXCM): Nisa Investment Advisors LLC lowered its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 53.9% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 34,228 shares of the medical device company’s stock after selling 40,004 shares during the quarter. Nisa Investment Advisors […] - 2025-07-14 05:50:57
Principal Financial Group Inc. Boosts Holdings in DexCom, Inc. (NASDAQ:DXCM): Principal Financial Group Inc. lifted its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 37.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 804,917 shares of the medical device company’s stock after purchasing an additional 219,965 shares during the […] - 2025-07-07 08:08:45
First Horizon Advisors Inc. Has $108,000 Stock Position in DexCom, Inc. (NASDAQ:DXCM): First Horizon Advisors Inc. increased its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 25.4% during the 1st quarter, Holdings Channel.com reports. The fund owned 1,582 shares of the medical device company’s stock after acquiring an additional 320 shares during the period. First Horizon Advisors Inc.’s holdings in DexCom were worth $108,000 […] - 2025-07-07 06:19:27

iShares S&P 500 Health Care Sector UCITS ETF USD (Acc) DXCM holdings

Date	Number of DXCM Shares Held	Base Market Value of DXCM Shares	Local Market Value of DXCM Shares	Change in DXCM Shares Held	Change in DXCM Base Value	Current Price per DXCM Share Held	Previous Price per DXCM Share Held
2025-09-18 (Thursday)	186,002	USD 14,095,232	USD 14,095,232	219	USD -106,021	USD 75.78	USD 76.44
2025-09-17 (Wednesday)	185,783	USD 14,201,253	USD 14,201,253	0	USD -20,436	USD 76.44	USD 76.55
2025-09-16 (Tuesday)	185,783	USD 14,221,689	USD 14,221,689	0	USD 180,210	USD 76.55	USD 75.58
2025-09-15 (Monday)	185,783	USD 14,041,479	USD 14,041,479
2025-09-12 (Friday)	185,783	USD 14,160,380	USD 14,160,380
2025-09-11 (Thursday)	185,209	USD 14,075,884	USD 14,075,884	218	USD 16,568	USD 76	USD 76
2025-09-10 (Wednesday)	184,991	USD 14,059,316	USD 14,059,316	218	USD -426,887	USD 76	USD 78.4
2025-09-09 (Tuesday)	184,773	USD 14,486,203	USD 14,486,203	0	USD 73,909	USD 78.4	USD 78
2025-09-08 (Monday)	184,773	USD 14,412,294	USD 14,412,294	0	USD -463,780	USD 78	USD 80.51

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of DXCM by Blackrock for IE00B43HR379

Show aggregate share trades of DXCM

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-09-18 BUY 219 75.780* 79.37
2025-09-11 BUY 218 76.000* 79.42
2025-09-10 BUY 218 76.000* 79.44
2025-08-20 BUY 432 81.670* 79.41
2025-08-19 BUY 216 80.900* 79.41
2025-07-17 SELL -217 84.100* 79.29 Profit of 17,206 on sale
2025-07-15 SELL -868 84.780* 79.23 Profit of 68,768 on sale
2025-07-14 SELL -2,170 85.330* 79.19 Profit of 171,840 on sale
2025-07-09 SELL -217 84.870* 79.09 Profit of 17,162 on sale
2025-07-07 SELL -434 82.940* 79.04 Profit of 34,301 on sale
2025-07-02 BUY 217 83.580* 78.96
2025-06-24 SELL -3,689 87.570* 78.72 Profit of 290,387 on sale
2025-06-23 BUY 217 79.840* 78.71
2025-06-20 SELL -434 80.000* 78.70 Profit of 34,156 on sale
2025-06-18 SELL -217 81.010* 78.67 Profit of 17,071 on sale
2025-06-17 BUY 2,604 81.830* 78.65
2025-06-13 SELL -434 81.990* 78.59 Profit of 34,110 on sale
2025-06-11 SELL -217 82.990* 78.53 Profit of 17,042 on sale
2025-06-10 SELL -434 84.820* 78.49 Profit of 34,064 on sale
2025-06-09 SELL -651 85.680* 78.44 Profit of 51,063 on sale
2025-05-21 SELL -216 84.890* 77.71 Profit of 16,785 on sale
2025-05-20 SELL -432 87.340* 77.63 Profit of 33,538 on sale
2025-05-15 SELL -648 85.670* 77.43 Profit of 50,174 on sale
2025-05-14 SELL -648 86.520* 77.35 Profit of 50,126 on sale
2025-05-13 BUY 216 84.110* 77.30
2025-05-09 SELL -216 84.670* 77.17 Profit of 16,669 on sale
2025-05-08 BUY 432 85.340* 77.10
2025-05-01 BUY 432 70.260* 77.00
2025-04-24 SELL -216 70.780* 77.27 Profit of 16,689 on sale
2025-04-23 BUY 648 66.860* 77.36
2025-04-15 SELL -216 69.230* 77.92 Profit of 16,832 on sale
2025-04-10 SELL -424 67.300* 78.26 Profit of 33,182 on sale
2025-04-08 SELL -212 60.690* 78.56 Profit of 16,655 on sale
2025-04-07 SELL -212 61.630* 78.74 Profit of 16,693 on sale
2025-04-04 SELL -424 59.830* 78.94 Profit of 33,471 on sale
2025-04-02 BUY 211 68.140* 79.06
2025-04-01 BUY 1,899 67.320* 79.19
2025-03-31 SELL -1,272 68.290* 79.31 Profit of 100,876 on sale
2025-03-28 BUY 212 67.740* 79.43
2025-03-26 SELL -139 72.130* 79.63 Profit of 11,069 on sale
2025-03-21 BUY 4,199 73.800* 79.82
2025-03-20 BUY 840 75.110* 79.88
2025-03-17 SELL -211 71.350* 80.18 Profit of 16,917 on sale
2025-03-12 SELL -1,193 70.760* 80.57 Profit of 96,117 on sale
2025-03-07 BUY 215 77.840* 80.87
2025-02-28 SELL -642 88.370* 80.66 Profit of 51,782 on sale
2025-02-25 BUY 2,140 88.320* 80.30
2025-02-20 BUY 1,498 89.340* 79.87
2025-02-19 BUY 642 89.680* 79.72
2025-02-18 BUY 428 90.530* 79.55
2025-02-13 BUY 1,065 84.090* 79.16
2025-02-04 BUY 852 87.460* 78.08
2025-01-31 BUY 213 86.830* 77.73
2025-01-29 BUY 213 86.430* 77.35
2025-01-27 BUY 426 87.530* 76.90
2025-01-24 BUY 213 88.750* 76.64
2025-01-22 BUY 852 87.090* 76.16
2024-12-10 SELL -216 79.410* 74.37 Profit of 16,064 on sale
2024-12-09 SELL -5,616 78.410* 74.24 Profit of 416,948 on sale
2024-12-03 SELL -2,568 80.910* 73.47 Profit of 188,676 on sale
2024-12-02 SELL -1,070 79.310* 73.26 Profit of 78,383 on sale
2024-11-29 SELL -217 77.990* 73.07 Profit of 15,857 on sale
2024-11-22 SELL -2,150 72.830* 72.15 Profit of 155,118 on sale
2024-11-21 SELL -1,075 74.460* 72.03 Profit of 77,435 on sale
2024-11-20 BUY 1,720 75.240* 71.86
2024-11-18 SELL -2,572 76.270* 71.43 Profit of 183,710 on sale
2024-11-11 BUY 1,926 70.310* 71.31
2024-11-08 SELL -6,848 69.960* 71.40 Profit of 488,972 on sale
2024-11-07 SELL -428 68.910* 71.60 Profit of 30,643 on sale
2024-11-01 SELL -428 70.350* 72.56 Profit of 31,058 on sale
2024-10-31 SELL -864 70.480* 72.83 Profit of 62,921 on sale
2024-10-30 BUY 216 71.800* 72.97
2024-10-29 BUY 1,296 72.240* 73.09
2024-10-28 SELL -648 72.100* 73.29 Profit of 47,493 on sale
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-09-18	BUY	219	75.780*	79.37
2025-09-11	BUY	218	76.000*	79.42
2025-09-10	BUY	218	76.000*	79.44
2025-08-20	BUY	432	81.670*	79.41
2025-08-19	BUY	216	80.900*	79.41
2025-07-17	SELL	-217	84.100*	79.29 Profit of 17,206 on sale
2025-07-15	SELL	-868	84.780*	79.23 Profit of 68,768 on sale
2025-07-14	SELL	-2,170	85.330*	79.19 Profit of 171,840 on sale
2025-07-09	SELL	-217	84.870*	79.09 Profit of 17,162 on sale
2025-07-07	SELL	-434	82.940*	79.04 Profit of 34,301 on sale
2025-07-02	BUY	217	83.580*	78.96
2025-06-24	SELL	-3,689	87.570*	78.72 Profit of 290,387 on sale
2025-06-23	BUY	217	79.840*	78.71
2025-06-20	SELL	-434	80.000*	78.70 Profit of 34,156 on sale
2025-06-18	SELL	-217	81.010*	78.67 Profit of 17,071 on sale
2025-06-17	BUY	2,604	81.830*	78.65
2025-06-13	SELL	-434	81.990*	78.59 Profit of 34,110 on sale
2025-06-11	SELL	-217	82.990*	78.53 Profit of 17,042 on sale
2025-06-10	SELL	-434	84.820*	78.49 Profit of 34,064 on sale
2025-06-09	SELL	-651	85.680*	78.44 Profit of 51,063 on sale
2025-05-21	SELL	-216	84.890*	77.71 Profit of 16,785 on sale
2025-05-20	SELL	-432	87.340*	77.63 Profit of 33,538 on sale
2025-05-15	SELL	-648	85.670*	77.43 Profit of 50,174 on sale
2025-05-14	SELL	-648	86.520*	77.35 Profit of 50,126 on sale
2025-05-13	BUY	216	84.110*	77.30
2025-05-09	SELL	-216	84.670*	77.17 Profit of 16,669 on sale
2025-05-08	BUY	432	85.340*	77.10
2025-05-01	BUY	432	70.260*	77.00
2025-04-24	SELL	-216	70.780*	77.27 Profit of 16,689 on sale
2025-04-23	BUY	648	66.860*	77.36
2025-04-15	SELL	-216	69.230*	77.92 Profit of 16,832 on sale
2025-04-10	SELL	-424	67.300*	78.26 Profit of 33,182 on sale
2025-04-08	SELL	-212	60.690*	78.56 Profit of 16,655 on sale
2025-04-07	SELL	-212	61.630*	78.74 Profit of 16,693 on sale
2025-04-04	SELL	-424	59.830*	78.94 Profit of 33,471 on sale
2025-04-02	BUY	211	68.140*	79.06
2025-04-01	BUY	1,899	67.320*	79.19
2025-03-31	SELL	-1,272	68.290*	79.31 Profit of 100,876 on sale
2025-03-28	BUY	212	67.740*	79.43
2025-03-26	SELL	-139	72.130*	79.63 Profit of 11,069 on sale
2025-03-21	BUY	4,199	73.800*	79.82
2025-03-20	BUY	840	75.110*	79.88
2025-03-17	SELL	-211	71.350*	80.18 Profit of 16,917 on sale
2025-03-12	SELL	-1,193	70.760*	80.57 Profit of 96,117 on sale
2025-03-07	BUY	215	77.840*	80.87
2025-02-28	SELL	-642	88.370*	80.66 Profit of 51,782 on sale
2025-02-25	BUY	2,140	88.320*	80.30
2025-02-20	BUY	1,498	89.340*	79.87
2025-02-19	BUY	642	89.680*	79.72
2025-02-18	BUY	428	90.530*	79.55
2025-02-13	BUY	1,065	84.090*	79.16
2025-02-04	BUY	852	87.460*	78.08
2025-01-31	BUY	213	86.830*	77.73
2025-01-29	BUY	213	86.430*	77.35
2025-01-27	BUY	426	87.530*	76.90
2025-01-24	BUY	213	88.750*	76.64
2025-01-22	BUY	852	87.090*	76.16
2024-12-10	SELL	-216	79.410*	74.37 Profit of 16,064 on sale
2024-12-09	SELL	-5,616	78.410*	74.24 Profit of 416,948 on sale
2024-12-03	SELL	-2,568	80.910*	73.47 Profit of 188,676 on sale
2024-12-02	SELL	-1,070	79.310*	73.26 Profit of 78,383 on sale
2024-11-29	SELL	-217	77.990*	73.07 Profit of 15,857 on sale
2024-11-22	SELL	-2,150	72.830*	72.15 Profit of 155,118 on sale
2024-11-21	SELL	-1,075	74.460*	72.03 Profit of 77,435 on sale
2024-11-20	BUY	1,720	75.240*	71.86
2024-11-18	SELL	-2,572	76.270*	71.43 Profit of 183,710 on sale
2024-11-11	BUY	1,926	70.310*	71.31
2024-11-08	SELL	-6,848	69.960*	71.40 Profit of 488,972 on sale
2024-11-07	SELL	-428	68.910*	71.60 Profit of 30,643 on sale
2024-11-01	SELL	-428	70.350*	72.56 Profit of 31,058 on sale
2024-10-31	SELL	-864	70.480*	72.83 Profit of 62,921 on sale
2024-10-30	BUY	216	71.800*	72.97
2024-10-29	BUY	1,296	72.240*	73.09
2024-10-28	SELL	-648	72.100*	73.29 Profit of 47,493 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of DXCM

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	2,244,349	123,900	7,301,108	30.7%
2025-09-18	2,096,398	2,923	4,473,314	46.9%
2025-09-17	1,005,017	909	2,841,630	35.4%
2025-09-16	832,635	1,252	1,662,428	50.1%
2025-09-15	415,979	19,554	1,507,100	27.6%
2025-09-12	479,180	25	1,013,014	47.3%
2025-09-11	1,239,171	19	3,292,844	37.6%
2025-09-10	778,899	1	2,102,775	37.0%
2025-09-09	398,555	48,137	1,042,556	38.2%
2025-09-08	597,379	10,948	1,743,480	34.3%
2025-09-05	490,229	0	992,181	49.4%
2025-09-04	833,267	24	1,699,659	49.0%
2025-09-03	1,673,104	582	3,096,450	54.0%
2025-09-02	559,125	6,032	1,379,296	40.5%
2025-08-29	395,483	819	767,429	51.5%
2025-08-28	480,565	39	1,612,270	29.8%
2025-08-27	422,875	756	1,106,762	38.2%
2025-08-26	451,911	15,387	1,316,342	34.3%
2025-08-25	801,886	5,802	2,158,071	37.2%
2025-08-22	279,355	5	826,312	33.8%
2025-08-21	331,378	4,639	798,573	41.5%
2025-08-20	491,337	399	1,003,276	49.0%
2025-08-19	311,145	1,383	842,816	36.9%
2025-08-18	509,896	0	1,182,266	43.1%
2025-08-15	351,714	12,102	630,748	55.8%
2025-08-14	394,332	438	858,593	45.9%
2025-08-13	530,063	302	1,270,620	41.7%
2025-08-12	533,812	115	1,296,848	41.2%
2025-08-11	673,352	144	1,432,682	47.0%
2025-08-08	812,111	647	1,314,352	61.8%
2025-08-07	679,883	11	1,091,906	62.3%
2025-08-06	902,331	283	2,029,615	44.5%
2025-08-05	598,249	68	2,057,698	29.1%
2025-08-04	942,525	17	3,002,291	31.4%
2025-08-01	1,104,059	1,225	2,117,218	52.1%
2025-07-31	1,973,583	3,744	3,201,771	61.6%
2025-07-30	484,427	82	1,520,136	31.9%
2025-07-29	414,317	112	885,534	46.8%
2025-07-28	545,711	900	1,158,616	47.1%
2025-07-25	439,501	851	1,018,375	43.2%
2025-07-24	314,578	49	750,090	41.9%
2025-07-23	342,609	311	689,820	49.7%
2025-07-22	354,194	17,613	750,057	47.2%
2025-07-21	308,164	9,508	783,241	39.3%
2025-07-18	312,697	18,442	836,608	37.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares S&P 500 Health Care Sector UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares V Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300QETNU1W5JY7Z94
ETF Ticker	IHCU(GBX) LSE
ETF Ticker	IUHC(USD) LSE
ETF Ticker	QDVG(EUR) F
ETF Ticker	IHCU.LS(GBX) CXE
ETF Ticker	IUHC.LS(USD) CXE
ETF Ticker	IUHCz(USD) CXE
ETF Ticker	QDVG.DE(EUR) CXE
ETF Ticker	IHCU.L(GBP) LSE
ETF Ticker	IUHC.L(GBP) LSE